Overview

Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Opioid medications are commonly used for pain relief. When given over time, physical dependence can occur. This results in unpleasant side effects--such as agitation and nausea--if opioid medications are suddenly stopped. We are interested in knowing if a medication named Ondansetron can help ease or prevent symptoms associated with opioid withdrawal. We are also interested in knowing if a similar (but more potent FDA-approved drug, palonosetron) can more effectively treat withdrawal symptoms with or without combination with an antihistamine called hydroxyzine (vistaril).
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Treatments:
Hydroxyzine
Ondansetron
Palonosetron